Materials and Methods
Polyvinyl acetate is a polymer (C4H502, molecular weight 43,000) soluble in greater than 55% ethanol (Fig. 1 ). Metrizamide and propylene glycol were added to this polymer for radiopacity and as a disinfectant, respectively. Three polyvinyl acetate solutions (PVac-1, 2, and 3) were prepared with various concentrations of polymer and ethanol (Table 1 ). The resultant PVac had sufficient radio paque agent (100 mgl/ml) for easy fluoroscopic con trol at injection. The solutions became gelatinous (reprecipitated) immediately upon contact with an aqueous environment but without adhesion to the catheter (Fig. 2) . To prevent reprecipitation inside the catheter, 25% ethanol was pre-injected in a volume equal to the dead space of the catheter (0.7 ml). Eighteen mongrel dogs were anesthetized with in travenous thiopental 15 mg/kg and pentobarbital 5 10 mg/kg, and maintained on spontaneous respira tion. Pre-embolization renal angiograms were ob tained by the femoral route using a 5 F catheter. A unilateral renal artery was embolized using a 5 F dou ble-lumen balloon catheter, with the tip positioned in the orifice of the artery. Embolizations were carried out with the balloon inflated.
The animals were divided into three groups. In the control group, two animals received sham emboliza tion using normal saline (0.3 ml/kg) infused over 20 minutes. The PVac group contained six animals. Em bolization was carried out using the three PVac (2.5-3.5 ml) infused over 4-7 minutes under fluoro scopic control in two animals each. The combined group contained 10 animals which all received em bolization with ethanol-estrogen (0.3 ml/kg) infused over 20 minutes, followed by infusion of PVac-2.
The catheter balloon was left inflated for 10 minutes after completion of infusion, then deflated and removed. Selective renal angiograms were per formed 15 minutes and 1 hour after embolization. All animals were allowed to recover from anesthesia. Animals in the control and PVac groups were sacrificed 4 days after embolization. Animals in the combined group were sacrificed after 1 hour (n = 2), 4 days (n = 4), 1 month (n = 2), and 3 months (n = 2). After perfusion fixation with 10% phosphate buffered formalin, the kidneys, adrenal glands, ab dominal aorta, and vena cava were removed en bloc. Specimens embolized with PVac were made into frozen sections and stained with ethanol-free HE to prevent dissolution of PVac. Angiograms demonstrated no changes in the con trol group. In the PVac group, polymer was ob served at the catheter tip at the end point of PVac-3 infusion. However, shortly after balloon deflation, fluoroscopy showed that the PVac-3 cast was pro pelled to the distal main trunk arteries. In contrast, no such movement was observed in PVac-1 or 2 treated animals after balloon deflation (Fig. 3 ). An giograms 4 days after embolization revealed occlu sion of the renal artery in all animals. In the com bined group, total obliteration was visualized after removal of the balloon catheter and in all follow-up angiograms (Fig. 4) .
No morphological changes in the vessels or renal tissue occurred in the control group. In the PVac and combined groups, polyvinyl acetate was observed as a yellow material within the arteries. In PVac-1 treated animals, polyvinyl acetate was distributed from the renal artery to the interlobular arteries. However, the peripheral arterioles and capillaries were not obliterated. (Fig. 5 ).
Complete renal arterial obliteration was observed in the combined group. Thrombosis was observed in arteries with a diameter of less than 100,um, and polyvinyl acetate was present in larger arteries. The renal artery and renal arterial trunk were completely obstructed by a mixture of polyvinyl acetate and thrombus (Fig. 6) . Fig. 3 PVac group. upper: Plain x-ray films immediately after injection of PVac-1 (left), 2 (center), and 3 (right). The radiopacity of the polyvinyl acetate cast (arrowheads) visualizes the renal arterial system. The double-lumen balloon (arrow) occludes the origin of the renal artery. lower: Selec tive right renal angiograms soon after injection of PVac-1 (left), 2 (center), and 3 (right). The casts of PVac-1 and 2 remain at the point of balloon inflation. The PVac-3 cast, however, has moved to the distal renal arterial trunk (arrow). The radiopacity of the polyvinyl acetate cast decreases after balloon removal due to parenchymal diffusion of contrast medium. in the PVac group, and at all times except 1 hour after embolization in the com bined group. The macroscopic appearance of the canine kidney in the combined group showed marked shrinkage (Fig. 7) . However, no undesirable tissue reactions, such as foreign body giant cell reactions, were observed in the infarcted parenchyma. Ethanol-free HE stain, x 100. lower: A mixture of polyvinyl acetate (asterisks) and thrombus is present in the lumen of interlobar arteries (arrows) and arterial trunk (double arrow). Ethanol-free HE stain, x 10.
Discussion
The ideal embolization material for treating vascular malformations and tumors should achieve: 1) a diffuse embolizing property which induces oblitera tion from artery to capillary without propagation into veins; 2) suitability for introduction through a tiny catheter as only superselective catheterization can preserve normal tissue circulation; 3) easy con trol with radiopacity, long infusion time to control the embolizing volume, and no adhesion to the catheter; 4) nontoxicity, biological inertness, and low reactivity to the normal parenchyma around the target lesion; 5) no recanalization following the em bolization; and 6) easy resection of embolized tissue.
Cyanoacrylate glue (isobutyl-2-cyanoacrylate: 113 CA, or N-butyl cyanoacrylate) is considered the best liquid embolization agent, 4"11) but there are technical difficulties due to incomplete embolization. Recent ly, Vinuela et al.22) reported on the effectiveness of this agent in a clinical review of long-term results in 30 patients with partially embolized arteriovenous malformations (AVMs). The main technical problem was related to inaccurate delivery of IBCA into the AVM nidus. In our opinion, this problem is related to the characteristics of IBCA, especially the ten dency to polymerize too quickly. Therefore, control is difficult to achieve during embolization. There are also more fundamental problems in volved in the use of single liquid polymer emboli zation materials. One is the volume change which occurs when a liquid material polymerizes to a solid. Another is the pulse of the arterial blood flow, which may result in a gap between the solidified embolus and the arterial wall. In addition, the embolization material and blood might mix if the blood flow is not controlled.
Such gaps and temporary coagulated blood could cause recanalization following emboliza tion. Furthermore, the whole vascular system, which contains microcirculation (capillaries) and large arteries, could not be obliterated if a single liquid em bolization material is used. Venous occlusion or pulmonary embolism might occur if the liquid em bolization material passes through the venous side,') or proximal occlusion if a liquid agent solidifies at the proximal side, causing development of collateral flow to the target lesion.
Combined administration of different types of em bolization agents, such as ethanol-estrogen followed by PVac, has not been previously reported. This method might solve some problems involved in the use of a single embolization agent. We reported that the embolization effect of ethanol-estrogen was as strong as that of absolute ethanol and that acute obliteration after the infusion of ethanol-estrogen oc curred initially in small vessels (< 10µm in diameter), then spread to larger vessels. This progressively oc clusive character of ethanol-estrogen has some unique thrombogenic or self-inflicted properties. However, acute vascular reaction occurred after infu sion of ethanol-estrogen, i.e., infiltration of microscopic red blood cells. Our study using PVac has shown that this can be prevented by occluding the main arterial flow using an additional liquid em bolization agent.
Peregrin et al.") first reported polyvinyl acetate as an embolization agent in 1984. We tested it in vitro and in vivo, and found a better combination with more diluted ethanol than the original 95% ethanol. We also use a different radiopaque material, metrizamide instead of lipiodol, to make a homogeneous radiopaque solution. The polyvinyl acetate used in our study had a molecular weight of 43,000 and structural formula of n = 500. This type of polyvinyl acetate was soluble in greater than 55% ethanol in our in vitro study. The in vivo study show ed the characteristics of PVac changed with the concentration of ethanol and polymer: PVac-3 pass ed through the capillaries with cast migration after removal of the double-lumen balloon catheter; PVac-2 reached arteries larger than 100 urn in diam eter; and PVac-1 reached the interlobular arteries without cast migration.
We selected PVac-2 for combined administration with ethanol-estrogen, be cause it did not pass to the venous side in the canine renal arterial system and it could be administered through a tiny catheter, such as a floppy-tip leak balloon catheter.19) Another type of PVac might be more useful in other vascular systems. Other poly vinyl acetates (n = 50-5000) are available for other vascular lesions, for example flow lesions or compo nents of the vascular structure. The PVac we used caused fewer parenchymal reactions, such as for eign body giant cells, during the follow-up period. We suggest that PVac is much more biologically inert and chemically stable than other liquid agents .20.21)
The physical, chemical, and biological properties of the ethanol-estrogen and PVac combination tested in our animal experiments are suitable for in travascular application, with fewer adverse tissue reactions, and provide a suitable embolization method for intravascular treatment. 
